drug · protein
patient view →leuprolide mesylate
Marketedupdated 2mo agoby Foresee Pharmaceuticals Co Ltd🔗 ChEMBL
Approvedcommunity read0 votes
Protein drug with a maximum clinical stage of Approval (across all indications), with an approval for prostate cancer and 1 investigational indication.
indications
investigational
Prostate Cancer
targets
Gonadotropin-releasing hormone receptor
all catalysts(0)
nothing on the calendar yet
News(0)
no news has mentioned this drug yet
comments(0)
5-min edit window · permanent after that